Evidence map›Paper›PMID 19741164›Full record

SynthesisDiabetes2009

SIRT1 genetic variation is related to BMI and risk of obesity.

M Carola Zillikens, Joyce B J van Meurs, Fernando Rivadeneira, Najaf Amin, Albert Hofman, Ben A Oostra, Eric J G Sijbrands, Jacqueline C M Witteman, Huibert A P Pols, Cornelia M van Duijn and 1 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Diabetes, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 136 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Exploring the Role ofJournal of clinical medicine · 2025
    Article
  8. Article
  9. Molecular Variants inInternational journal of women's health · 2025
    Article
  10. Genetic variants inFrontiers in genetics · 2024
    Article
  11. Analysis ofFrontiers in genetics · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Genetic Variants ofInternational journal of endocrinology · 2023
    Article
  17. Review
  18. Article
  19. Observational
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

M Carola ZillikensDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands. m.c.zillikens@erasmusmc.nl
Joyce B J van Meurs
Fernando Rivadeneira
Najaf Amin
Albert Hofman
Ben A Oostra
Eric J G Sijbrands
Jacqueline C M Witteman
Huibert A P Pols
Cornelia M van Duijn
André G Uitterlinden
Erasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSIRT1 has pleiotropic metabolic functions. We investigated whether SIRT1 genetic variation is associated with obesity. RESEARCH DESIGN AND

methodsIn 6,251 elderly subjects from the prospective, population-based Rotterdam Study, three single nucleotide polymorphisms (SNPs) in the SIRT1 gene were studied in relation to BMI and risk of obesity (BMI > or =30 kg/m(2)) and prospectively with BMI change after 6.4 years of follow-up. We used cross-sectional data from 2,347 participants from the Erasmus Rucphen Family (ERF) study for replication.

resultsMinor alleles of rs7895833 (G = 20.2%) and rs1467568 (A = 36.8%) were associated with lower BMI in the Rotterdam Study (P = 0.02 and 0.04) and in the replication cohort ERF study (P = 0.03 and 0.008) and in both studies combined (P = 0.002 for both SNPs), with a 0.2-0.4 kg/m(2) decrease in BMI per allele copy. Carriers of these alleles had 13-18% decreased risk of obesity (for rs7895833 in the Rotterdam Study: odds ratio 0.79 [95% CI 0.67-0.94], P = 0.007; in the ERF study: 0.93 [0.73-1.19], P = 0.37; and in the studies combined 0.87 [0.77-0.97], P = 0.02; for rs1467568 in the Rotterdam Study: 0.80 [0.68-0.94], P = 0.007; in the ERF study: 0.85 [0.72-0.99], P = 0.04; and in the studies combined: 0.82 [0.73-0.92], P = 0.0009). In the Rotterdam Study, the two variants were also associated with a lower BMI increase during 6.4 years of follow-up (P = 0.01 and 0.08).

conclusionsTwo common variants in SIRT1 are associated with lower BMI in two independent Dutch populations. Carriers of these variants have 13-18% decreased risk of obesity and gain less weight over time. The availability of SIRT1 stimulators makes these findings relevant in light of the growing obesity epidemic.

Indexed as

Body Mass IndexPolymorphism, Single NucleotideAgedFemaleFollow-Up StudiesGenetic VariationGenotypeHaplotypesHumansMaleNetherlandsObesityOverweightProspective StudiesRisk AssessmentSirtuin 1SIRT1 protein, humanSirtuin 1

Identifiers

PMID19741164
PMCPMC2780870
OpenAlexW2052210065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.